Track the latest Coeptis Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Coeptis Therapeutics stock.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
Insiders have report no purchases/sales in the last 30 days.
There has been no Insider buying or selling in the last 90 days.
Jan 17, 2024 | Brian Cogley | CHIEF FINANCIAL OFFICER | 5.00K | $0.67 | $3.35K | BUY | 20.00% | 30.00K | Jan 10 | View |
Jan 16, 2024 | Tara DeSilva | DIRECTOR | 2.27K | $0.58 | $1.30K | BUY | 7.55% | 32.27K | Jan 12 | View |
Jan 09, 2024 | Daniel A. Yerace | VP OPERATIONS | 10.85K | $0.69 | $7.49K | BUY | 1.02% | 1.07M | Jan 05 | View |
Jan 09, 2024 | Gene Salkind | DIRECTOR | 11.60K | $0.69 | $8.00K | BUY | 4.20% | 288.10K | Jan 05 | View |
Jan 09, 2024 | David Mehalick | CEO AND PRESIDENT | 25.05K | $0.67 | $16.75K | BUY | 0.91% | 2.78M | Jan 05 - Jan 08 | View |
Jan 09, 2024 | Christopher P Cochran | DIRECTOR | 7.00K | $0.77 | $5.39K | BUY | 23.33% | 37.00K | Jan 05 | View |
Aug 31, 2023 | Chris Calise | DIRECTOR | 11.58K | $0.94 | $10.88K | BUY | 0.80% | 1.46M | Aug 23 | View |
Aug 30, 2023 | Gene Salkind | DIRECTOR | 32.64K | $0.92 | $30.11K | BUY | 14.74% | 254.09K | Aug 25 - Aug 29 | View |
Nov 18, 2021 | David Mehalick | CEO AND PRESIDENT | -1.20M | $0.00 | $0.00 | SELL | -40.00% | 1.80M | Nov 16 | View |
Browse insider trades on all stocks.